Literature DB >> 2564578

Buspirone in treatment of premenstrual syndrome.

K Rickels, E Freeman, S Sondheimer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2564578     DOI： 10.1016/s0140-6736(89)92591-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  16 in total

Review 1.  Current update of hormonal and psychotropic drug treatment of premenstrual dysphoric disorder.

Authors:  Ellen W Freeman
Journal:  Curr Psychiatry Rep       Date:  2002-12       Impact factor: 5.285

Review 2.  Effects of antidepressants on quality of life in women with premenstrual dysphoric disorder.

Authors:  Ellen W Freeman
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

3.  Premenstrual dysphoric disorder: burden of illness and treatment update.

Authors:  Teri Pearlstein; Meir Steiner
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186

Review 4.  Are there differential symptom profiles that improve in response to different pharmacological treatments of premenstrual syndrome/premenstrual dysphoric disorder?

Authors:  Uriel Halbreich; P M Shaughn O'Brien; Elias Eriksson; Torbjörn Bäckström; Kimberly A Yonkers; Ellen W Freeman
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 5.  Premenstrual syndrome and premenstrual dysphoric disorder: guidelines for management.

Authors:  M Steiner
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

6.  Low-dose acetazolamide in the treatment of premenstrual dysphoric disorder: a case series.

Authors:  Gabriele Sani; Georgios D Kotzalidis; Isabella Panaccione; Alessio Simonetti; Lavinia De Chiara; Antonio Del Casale; Elisa Ambrosi; Flavia Napoletano; Delfina Janiri; Emanuela Danese; Nicoletta Girardi; Chiara Rapinesi; Daniele Serata; Giovanni Manfredi; Alexia E Koukopoulos; Gloria Angeletti; Ferdinando Nicoletti; Paolo Girardi
Journal:  Psychiatry Investig       Date:  2014-01-21       Impact factor: 2.505

Review 7.  The role of central serotonergic dysfunction in the aetiology of premenstrual dysphoric disorder: therapeutic implications.

Authors:  B L Parry
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 8.  Premenstrual syndrome. Identification and management.

Authors:  S K Severino; M L Moline
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

Review 9.  Luteal phase administration of agents for the treatment of premenstrual dysphoric disorder.

Authors:  Ellen W Freeman
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 10.  Update on research and treatment of premenstrual dysphoric disorder.

Authors:  Joanne Cunningham; Kimberly Ann Yonkers; Shaughn O'Brien; Elias Eriksson
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.